Biodesix outlines $106M–$112M 2026 revenue target as sales expansion drives 41% Q4 growth (NASDAQ:BDSX)

Biodesix (BDSX) Q4 2025 earnings call recap: 41% revenue growth, first positive EBITDA, 2026 guidance and key risks.

You will be redirected in 10 seconds.